RecruitingNot ApplicableNCT05338294
The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on the Immune Function for Cirrhosis Patients
Sponsor
Northern Jiangsu People's Hospital
Enrollment
20 participants
Start Date
Mar 1, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
In this study, the investigators compared the improvement of immune function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
- Splenomegaly with secondary hypersplenism
- gastroesophageal variceal bleeding
- Informed consent to participate in the study
Exclusion Criteria7
- Hepatocellular carcinoma or any other malignancy,
- Child-Pugh grade C
- Recent peptic ulcer disease
- History of Hemorrhagic stroke
- Pregnancy.
- Uncontrolled Hypertension
- Human immunodeficiency virus (HIV) infection
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURELaparoscopic splenectomy and azygoportal disconnection
Laparoscopic splenectomy and azygoportal disconnection is performed by the same surgical team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05338294
Related Trials
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
NCT065256231 location
Transitional Care Program for Fluid Overload in Cirrhosis
NCT061742721 location
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
NCT048679541 location
Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
NCT074298641 location
Development of an Italian Questionnaire for Splenectomized Patients Using a Delphi Consensus Method
NCT074280051 location